Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Capital Leases: 2010-2017

Historic Capital Leases for Neurocrine Biosciences (NBIX) over the last 6 years, with Mar 2017 value amounting to $544,000.

  • Neurocrine Biosciences' Capital Leases fell 32.76% to $544,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $544,000, marking a year-over-year decrease of 32.76%. This contributed to the annual value of $617,000 for FY2016, which is 60.32% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Capital Leases of $544,000 as of Q1 2017, which was down 11.83% from $617,000 recorded in Q4 2016.
  • Neurocrine Biosciences' Capital Leases' 5-year high stood at $3.0 million during Q1 2013, with a 5-year trough of $544,000 in Q1 2017.
  • For the 3-year period, Neurocrine Biosciences' Capital Leases averaged around $1.2 million, with its median value being $809,000 (2016).
  • Its Capital Leases has fluctuated over the past 5 years, first soared by 32.63% in 2013, then plummeted by 61.22% in 2016.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Capital Leases stood at $2.7 million in 2013, then dropped by 17.50% to $2.2 million in 2014, then fell by 29.67% to $1.6 million in 2015, then crashed by 60.32% to $617,000 in 2016, then slumped by 32.76% to $544,000 in 2017.
  • Its Capital Leases stands at $544,000 for Q1 2017, versus $617,000 for Q4 2016 and $649,000 for Q3 2016.